|
US4200750A
(en)
|
1977-01-07 |
1980-04-29 |
Westwood Pharmaceuticals Inc. |
4-Substituted imidazo [1,2-a]quinoxalines
|
|
EP0346841A3
(de)
|
1988-06-16 |
1991-01-09 |
Ciba-Geigy Ag |
1-Aryl-naphthoesäureamide und diese enthaltende mikrobizide Mittel
|
|
MX16687A
(es)
|
1988-07-07 |
1994-01-31 |
Ciba Geigy Ag |
Compuestos de biarilo y procedimiento para su preparacion.
|
|
EP0430033A3
(en)
|
1989-11-24 |
1991-09-11 |
Ciba-Geigy Ag |
Microbicidal agents
|
|
ES2162792T3
(es)
|
1991-09-18 |
2002-01-16 |
Glaxo Group Ltd |
Derivados de benzanilida como antagonistas de 5-ht1d.
|
|
GB9119920D0
(en)
|
1991-09-18 |
1991-10-30 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB9816837D0
(en)
|
1998-08-04 |
1998-09-30 |
Zeneca Ltd |
Amide derivatives
|
|
US5246943A
(en)
|
1992-05-19 |
1993-09-21 |
Warner-Lambert Company |
Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties
|
|
US5236934A
(en)
|
1992-08-26 |
1993-08-17 |
E. I. Du Pont De Nemours And Company |
1,2,3,4-tetrahydroisoquinolines useful in the treatment of CNS disorders
|
|
GB2273930A
(en)
|
1992-12-30 |
1994-07-06 |
Glaxo Group Ltd |
Benzanilide derivatives
|
|
TW240217B
(enExample)
|
1992-12-30 |
1995-02-11 |
Glaxo Group Ltd |
|
|
IL108630A0
(en)
|
1993-02-18 |
1994-05-30 |
Fmc Corp |
Insecticidal substituted 2,4-diaminoquinazolines
|
|
GB2276161A
(en)
|
1993-03-17 |
1994-09-21 |
Glaxo Group Ltd |
Aniline and benzanilide derivatives
|
|
GB2276162A
(en)
|
1993-03-17 |
1994-09-21 |
Glaxo Group Ltd |
Aniline and benazilide derivatives
|
|
CN1129933A
(zh)
|
1993-08-31 |
1996-08-28 |
辉瑞大药厂 |
5-芳基吲哚衍生物
|
|
WO1995006644A1
(en)
|
1993-09-03 |
1995-03-09 |
Smithkline Beecham Plc |
Amide derivatives as 5ht1d receptor antagonists
|
|
EP0724580A1
(en)
|
1993-10-19 |
1996-08-07 |
Smithkline Beecham Plc |
Benzanilide derivatives as 5ht-1d receptor antagonists
|
|
JPH09506101A
(ja)
|
1993-12-07 |
1997-06-17 |
スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー |
５ｈｔ１ｄ拮抗薬として有用な複素環式ビフェニリルアミド類
|
|
GB9326008D0
(en)
|
1993-12-21 |
1994-02-23 |
Smithkline Beecham Plc |
Novel compounds
|
|
GB9408577D0
(en)
|
1994-04-29 |
1994-06-22 |
Fujisawa Pharmaceutical Co |
New compound
|
|
JPH09512804A
(ja)
|
1994-05-06 |
1997-12-22 |
スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー |
５−ｈｔ１ｄアンタゴニストとして有用なビフェニルカルボキシアミド類
|
|
US5521213A
(en)
|
1994-08-29 |
1996-05-28 |
Merck Frosst Canada, Inc. |
Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
|
|
GB2295387A
(en)
|
1994-11-23 |
1996-05-29 |
Glaxo Inc |
Quinazoline antagonists of alpha 1c adrenergic receptors
|
|
EP0819127A1
(en)
|
1995-04-04 |
1998-01-21 |
Glaxo Group Limited |
IMIDAZO [1,2-a]PYRIDINE DERIVATIVES
|
|
GB9507203D0
(en)
|
1995-04-07 |
1995-05-31 |
Smithkline Beecham Plc |
Novel compounds
|
|
US5658903A
(en)
|
1995-06-07 |
1997-08-19 |
Smithkline Beecham Corporation |
Imidazole compounds, compositions and use
|
|
CA2226849A1
(en)
|
1995-07-10 |
1997-01-30 |
Zenon Lysenko |
Stable polynitrile oxides and their use as curing agent especially for latex
|
|
EP1304322A3
(en)
|
1995-08-22 |
2003-11-19 |
Japan Tobacco Inc. |
Carboxylic acid compound and use thereof
|
|
US6080767A
(en)
*
|
1996-01-02 |
2000-06-27 |
Aventis Pharmaceuticals Products Inc. |
Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
|
|
US6323227B1
(en)
*
|
1996-01-02 |
2001-11-27 |
Aventis Pharmaceuticals Products Inc. |
Substituted N-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
|
|
ES2205167T3
(es)
|
1996-01-11 |
2004-05-01 |
Smithkline Beecham Corporation |
Nuevos compuestos de imidazol sustituidos.
|
|
FR2754260B1
(fr)
|
1996-10-04 |
1998-10-30 |
Adir |
Nouveaux derives substitues de biphenyle ou de phenylpyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
US6147080A
(en)
|
1996-12-18 |
2000-11-14 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of p38
|
|
US5945418A
(en)
|
1996-12-18 |
1999-08-31 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of p38
|
|
US6087496A
(en)
|
1998-05-22 |
2000-07-11 |
G. D. Searle & Co. |
Substituted pyrazoles suitable as p38 kinase inhibitors
|
|
PL336990A1
(en)
|
1997-05-22 |
2000-07-31 |
Searle & Co |
3(5)-heteroaryl group substituted pyrazoles as inhibitors of kinase p 38
|
|
EP1023066A4
(en)
|
1997-06-13 |
2001-05-23 |
Smithkline Beecham Corp |
NEW PYRAZOLE AND PYRAZOLINE SUBSTITUTED COMPOUND
|
|
AU7976998A
(en)
|
1997-06-19 |
1999-01-04 |
Du Pont Merck Pharmaceutical Company, The |
(amidino)6-membered aromatics as factor xa inhibitors
|
|
US6060491A
(en)
|
1997-06-19 |
2000-05-09 |
Dupont Pharmaceuticals |
6-membered aromatics as factor Xa inhibitors
|
|
US6251914B1
(en)
|
1997-07-02 |
2001-06-26 |
Smithkline Beecham Corporation |
Cycloalkyl substituted imidazoles
|
|
CA2303152A1
(en)
|
1997-09-05 |
1999-03-18 |
Glaxo Group Limited |
2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors
|
|
KR100340273B1
(ko)
*
|
1997-10-14 |
2002-06-14 |
야마모토 카즈모토 |
비페닐-5-알칸산 유도체 및 이의 용도
|
|
IL136737A0
(en)
|
1997-12-22 |
2001-06-14 |
Bayer Ag |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
|
JPH11218884A
(ja)
|
1998-02-03 |
1999-08-10 |
Konica Corp |
ハロゲン化銀写真感光材料
|
|
DE19817461A1
(de)
|
1998-04-20 |
1999-10-21 |
Basf Ag |
Neue substituierte Benzamide, deren Herstellung und Anwendung
|
|
ATE282590T1
(de)
|
1998-05-15 |
2004-12-15 |
Astrazeneca Ab |
Benzamid-derivate zur behandlung cytokin- vermittelter krankheiten
|
|
US6867209B1
(en)
|
1998-05-22 |
2005-03-15 |
Scios, Inc. |
Indole-type derivatives as inhibitors of p38 kinase
|
|
US6448257B1
(en)
|
1998-05-22 |
2002-09-10 |
Scios, Inc. |
Compounds and methods to treat cardiac failure and other disorders
|
|
US6130235A
(en)
|
1998-05-22 |
2000-10-10 |
Scios Inc. |
Compounds and methods to treat cardiac failure and other disorders
|
|
IL141724A0
(en)
|
1998-08-28 |
2002-03-10 |
Scios Inc |
INHIBITORS OF P38-α KINASE
|
|
US6184226B1
(en)
|
1998-08-28 |
2001-02-06 |
Scios Inc. |
Quinazoline derivatives as inhibitors of P-38 α
|
|
JP2002526482A
(ja)
*
|
1998-09-18 |
2002-08-20 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
ｐ３８のインヒビター
|
|
CN1263755C
(zh)
|
1998-11-03 |
2006-07-12 |
葛兰素集团有限公司 |
作为选择性cox－2抑制剂的吡唑并吡啶衍生物
|
|
EP1140840B1
(en)
|
1999-01-13 |
2006-03-22 |
Bayer Pharmaceuticals Corp. |
-g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
US6545054B1
(en)
|
1999-02-11 |
2003-04-08 |
Millennium Pharmaceuticals, Inc. |
Alkenyl and alkynyl compounds as inhibitors of factor Xa
|
|
DE69915519T2
(de)
|
1999-02-27 |
2005-02-03 |
Glaxo Group Ltd., Greenford |
Pyrazolopyridine
|
|
GB9906566D0
(en)
|
1999-03-23 |
1999-05-19 |
Zeneca Ltd |
Chemical compounds
|
|
US6509361B1
(en)
|
1999-05-12 |
2003-01-21 |
Pharmacia Corporation |
1,5-Diaryl substituted pyrazoles as p38 kinase inhibitors
|
|
CA2374820A1
(en)
|
1999-05-24 |
2000-11-30 |
Cor Therapeutics, Inc. |
Inhibitors of factor xa
|
|
JP2003500386A
(ja)
|
1999-05-24 |
2003-01-07 |
シーオーアール セラピューティクス インコーポレイテッド |
Ｘａ因子阻害剤
|
|
JP2003500376A
(ja)
|
1999-05-24 |
2003-01-07 |
シーオーアール セラピューティクス インコーポレイテッド |
Ｘａ因子の阻害剤
|
|
DE19932571A1
(de)
|
1999-07-13 |
2001-01-18 |
Clariant Gmbh |
Verfahren zur Herstellung von Biarylen unter Palladophosphacyclobutan-Katalyse
|
|
GB9919778D0
(en)
|
1999-08-21 |
1999-10-27 |
Zeneca Ltd |
Chemical compounds
|
|
US6576632B1
(en)
|
1999-08-27 |
2003-06-10 |
Pfizer Inc |
Biaryl compounds useful as anticancer agents
|
|
GB9924092D0
(en)
|
1999-10-13 |
1999-12-15 |
Zeneca Ltd |
Pyrimidine derivatives
|
|
MXPA01007019A
(es)
|
1999-11-10 |
2002-09-18 |
Johnson & Johnson |
2-aril-3-(heteroaril)-imidazo[1,2-a]pirimidinas, sustituidas y composiciones farmaceuticas relacionados y metodos.
|
|
WO2001070695A1
(en)
|
2000-03-22 |
2001-09-27 |
Vertex Pharmaceuticals Incorporated |
Pyridine derivatives as inhibitors of p38
|
|
EP1283208A4
(en)
|
2000-05-18 |
2003-08-13 |
Daiichi Seiyaku Co |
NEW BENZOFURAN DERIVATIVES
|
|
PE20020506A1
(es)
|
2000-08-22 |
2002-07-09 |
Glaxo Group Ltd |
Derivados de pirazol fusionados como inhibidores de la proteina cinasa
|
|
DK1363910T3
(da)
|
2000-11-17 |
2006-06-26 |
Bristol Myers Squibb Co |
Fremgangsmåder til behandling af P39-kinase-associerede tilstande og pyrrolotriazinforbindelser, der er anvendelige som kinase-inhibitorer
|
|
DE10059418A1
(de)
|
2000-11-30 |
2002-06-20 |
Aventis Pharma Gmbh |
Ortho, meta-substituierte Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
|
|
DE10060807A1
(de)
|
2000-12-07 |
2002-06-20 |
Aventis Pharma Gmbh |
Ortho, ortho-substituierte stickstoffhaltige Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
|
|
DE10063008A1
(de)
|
2000-12-16 |
2002-06-20 |
Merck Patent Gmbh |
Carbonsäureamidderivate
|
|
DE10110749A1
(de)
|
2001-03-07 |
2002-09-12 |
Bayer Ag |
Substituierte Aminodicarbonsäurederivate
|
|
DE60210755T2
(de)
|
2001-03-09 |
2006-11-16 |
Pfizer Products Inc., Groton |
Triazolopyridine als entzündungshemmende mittel
|
|
ES2332090T3
(es)
|
2001-04-06 |
2010-01-26 |
Biocryst Pharmaceuticals, Inc. |
Compuestos biarilicos como inhibidores de serina proteasa.
|
|
FR2824827B1
(fr)
*
|
2001-05-17 |
2004-02-13 |
Fournier Lab Sa |
Nouveaux derives de 5-phenyl-1h-indole antagoniste des recepteurs de l'interleukine-8
|
|
AR037233A1
(es)
|
2001-09-07 |
2004-11-03 |
Euro Celtique Sa |
Piridinas aril sustituidas, composiciones farmaceuticas y el uso de dichos compuestos para la elaboracion de un medicamento
|
|
GB0124848D0
(en)
|
2001-10-16 |
2001-12-05 |
Celltech R&D Ltd |
Chemical compounds
|
|
GB0124932D0
(en)
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124941D0
(en)
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124939D0
(en)
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124931D0
(en)
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124933D0
(en)
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124928D0
(en)
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124934D0
(en)
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124936D0
(en)
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124938D0
(en)
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
JP4472349B2
(ja)
|
2002-02-12 |
2010-06-02 |
スミスクライン ビーチャム コーポレーション |
ｐ３８阻害薬として有用なニコチンアミド誘導体
|
|
US20030225089A1
(en)
|
2002-04-10 |
2003-12-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
|
|
GB0209891D0
(en)
|
2002-04-30 |
2002-06-05 |
Glaxo Group Ltd |
Novel compounds
|
|
GB0217757D0
(en)
|
2002-07-31 |
2002-09-11 |
Glaxo Group Ltd |
Novel compounds
|
|
US20040116479A1
(en)
|
2002-10-04 |
2004-06-17 |
Fortuna Haviv |
Method of inhibiting angiogenesis
|
|
US7136850B2
(en)
|
2002-12-20 |
2006-11-14 |
International Business Machines Corporation |
Self tuning database retrieval optimization using regression functions
|
|
GB0308185D0
(en)
*
|
2003-04-09 |
2003-05-14 |
Smithkline Beecham Corp |
Novel compounds
|
|
GB0308186D0
(en)
|
2003-04-09 |
2003-05-14 |
Smithkline Beecham Corp |
Novel compounds
|
|
GB0308201D0
(en)
|
2003-04-09 |
2003-05-14 |
Smithkline Beecham Corp |
Novel compounds
|
|
MXPA06000915A
(es)
|
2003-07-25 |
2006-03-30 |
Novartis Ag |
Inhibidores de quinasa p-38.
|
|
GB0318814D0
(en)
|
2003-08-11 |
2003-09-10 |
Smithkline Beecham Corp |
Novel compounds
|
|
GB0402140D0
(en)
|
2004-01-30 |
2004-03-03 |
Smithkline Beecham Corp |
Novel compounds
|
|
GB0402137D0
(en)
|
2004-01-30 |
2004-03-03 |
Smithkline Beecham Corp |
Novel compounds
|
|
GB0402143D0
(en)
|
2004-01-30 |
2004-03-03 |
Smithkline Beecham Corp |
Novel compounds
|
|
GB0402138D0
(en)
|
2004-01-30 |
2004-03-03 |
Smithkline Beecham Corp |
Novel compounds
|